Dr Don Hamson presents Plato Income Maximiser Limited’s (ASX:PL8) results for the half-year ended 31 December (FY25).
Read More
View Plato Income Maximiser’s (ASX:PL8) results summary for the half-year ended 31 December
2024 (FY25).
Dr David Allen provides his insights on the potential of GLP-1s to combat substance abuse, and what this ultimately means for investors.
The bank is priced like a growth stock and certainly no longer delivers a great yield. But should investors still consider CBA?
Dr David Allen provides an overview of the Plato Global Alpha Complex ETF, now available to investors on the ASX under the ticker: PGA1.
View Plato Income Maximiser’s (ASX:PL8) results summary for the full-year ended 30 June
2024 (FY24).
You can own mega cap growth stocks and sleep at night too.
View Plato Income Maximiser Limited’s (ASX:PL8) results webinar for the half-year ended 31 December 2023 (FY24).
View Plato Income Maximiser’s (ASX:PL8) results summary for the half-year ended 31 December
2023 (FY24).
Is the very logic used to argue in favour of passive investing, starting to work against it?
